Ledger.Open graph →
SEC Form D · filed July 25, 2025

EnteroBiotix LTD

Offering
—
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLASGOW, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Mark Bamforth · Glasgow, United KingdomDirectorDavid Lawrence · Glasgow, United KingdomDirectorElmar J. Schnee · Glasgow, United KingdomDirectorIain Baird · Glasgow, United KingdomDirectorDouglas C. Thomson · Glasgow, United KingdomDirectorJames R. Mcilroy · Glasgow, United KingdomExec · DirectorFelix A. Olale · Glasgow, United KingdomDirectorMark Bamforth · Glasgow, United KingdomDirectorElmar J. Schnee · Glasgow, United KingdomDirectorDavid Lawrence · Glasgow, United KingdomDirectorDouglas C. Thomson · Glasgow, United KingdomDirectorIain Baird · Glasgow, United KingdomDirectorFelix A. Olale · Glasgow, United KingdomDirectorMelissa C. Strange · Glasgow, United KingdomExecJames C. Barnes · Glasgow, United KingdomExecMaximo Reca · Buenos Aires, C1DirectorNicolas Kolliker Frers · Buenos Aires, C1DirectorSantiago Schmidt Prim · Buenos Aires, C1DirectorChristopher Lawrence · Montgomery, TXDirectorMatthew Renner · Montgomery, TXDirectorMelissa C. Strange · Glasgow, United KingdomExecJames C. Barnes · Glasgow, United KingdomExecJames R. Mcilroy · Glasgow, United KingdomExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗